ARCHIVES

Pryor Bill Embodies Drug Company Fears

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

July 12, 1991

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

July 27, 1984

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998